Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
UGI
UGI
$8.06B
| $59.4M | 0.03% |
2,200,693
+1,705,527
| +344% | +$51.8M |
|
627
Pfizer
PFE
$160B
| $59.2M | 0.03% |
1,613,796
+639,938
| +66% | +$24.9M |
|
628
Union Pacific
UNP
$183B
| $59.2M | 0.03% |
289,105
-330,528
| -53% | -$65.7M |
|
629
Huntsman Corp
HUN
$1.75B
| $59M | 0.03% |
2,182,030
+981,174
| +82% | +$25.5M |
|
630
Royal Gold
RGLD
$21.9B
| $58.8M | 0.03% |
512,500
-407,013
| -44% | -$52.4M |
|
631
Kinsale Capital Group
KNSL
$8.74B
| $58.6M | 0.03% |
156,660
+155,912
| +20,844% | +$51.8M |
|
|
MRO
632
DELISTED
Marathon Oil Corporation
MRO
| $58.5M | 0.03% |
2,542,896
-1,536,831
| -38% | -$36.2M |
|
633
Yum! Brands
YUM
$41.8B
| $58.5M | 0.03% |
422,429
-293,011
| -41% | -$39.7M |
|
634
Nutrien
NTR
$35.9B
| $57.9M | 0.03% |
+981,127
| New | +$62.4M |
|
635
Shutterstock
SSTK
$197M
| $57.9M | 0.03% |
1,190,312
+976,067
| +456% | +$55.6M |
|
636
Vanguard Real Estate ETF
VNQ
$39.1B
| $57.8M | 0.03% |
692,061
+559,555
| +422% | +$45.8M |
|
637
Jefferies Financial Group
JEF
$12.1B
| $57.8M | 0.03% |
1,741,881
+633,800
| +57% | +$19.8M |
|
638
Broadcom
AVGO
$1.75T
| $57.7M | 0.03% |
665,380
+336,390
| +102% | +$24M |
|
639
Royalty Pharma
RPRX
$27.3B
| $57.6M | 0.03% |
1,875,227
-163,655
| -8% | -$5.54M |
|
640
SentinelOne
S
$7.26B
| $57.5M | 0.03% |
3,808,866
+2,272,526
| +148% | +$38.4M |
|
641
PUT
FedEx
FDX
$76.9B
| $57.3M | 0.03% |
231,100
-721,600
| -76% | -$165M |
|
642
Delta Air Lines
DAL
$54.2B
| $57.3M | 0.03% |
1,204,275
+73,274
| +6% | +$2.7M |
|
643
Globe Life
GL
$13.1B
| $57M | 0.03% |
519,738
+323,896
| +165% | +$34.8M |
|
644
Truist Financial
TFC
$61.6B
| $56.9M | 0.03% |
1,875,334
+1,564,007
| +502% | +$48.6M |
|
645
Commercial Metals
CMC
$7.34B
| $56.8M | 0.03% |
1,078,732
+568,964
| +112% | +$26.5M |
|
646
CALL
Altria Group
MO
$110B
| $56.8M | 0.03% |
1,252,800
-974,600
| -44% | -$44.1M |
|
647
CALL
Intel
INTC
$476B
| $56.7M | 0.03% |
1,696,100
+14,700
| +0.9% | +$462K |
|
|
RETA
648
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $56.7M | 0.03% |
556,264
+342,204
| +160% | +$32.4M |
|
649
RBC Bearings
RBC
$16B
| $56.6M | 0.03% |
+260,134
| New | +$56.4M |
|
650
Teradata
TDC
$2.58B
| $56.1M | 0.03% |
1,049,947
-115,759
| -10% | -$5.22M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.